Hacker News
new
|
past
|
comments
|
ask
|
show
|
jobs
|
submit
login
aianus
on Oct 23, 2013
|
parent
|
context
|
favorite
| on:
Dr. Arjun Srinivasan: We’ve Reached “The End of An...
They could patent it and charge $5000 a course to people who are suffering from resistant bacteria. It's the American way.
pimentel
on Oct 24, 2013
[–]
If that's what's necessary for the company to develop such an antibiotic, why not? State-of-the-art cancer drugs can cost that ore more. I'd rather pay $5k and live, to not being able to do anything.
Guidelines
|
FAQ
|
Lists
|
API
|
Security
|
Legal
|
Apply to YC
|
Contact
Search:
